Free Trial
NYSE:BTX

Brooklyn ImmunoTherapeutics (BTX) Stock Price, News & Analysis

Brooklyn ImmunoTherapeutics logo
$7.08 -0.12 (-1.67%)
As of 07/11/2025 03:59 PM Eastern

About Brooklyn ImmunoTherapeutics Stock (NYSE:BTX)

Key Stats

Today's Range
$7.02
$7.20
50-Day Range
$6.40
$7.44
52-Week Range
$5.10
$8.31
Volume
525,137 shs
Average Volume
745,656 shs
Market Capitalization
$416.49 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive BTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Brooklyn ImmunoTherapeutics and its competitors with MarketBeat's FREE daily newsletter.

BTX Stock News Headlines

Forget Nvidia, This “Ghost Town” Company Holds the Key to the AI Boom
Cold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to investigate this crazy Cold War story… Because it could hold the key to the entire $100 trillion AI boom. It involves an American ghost town with just 30 people… And a new twist to the AI boom that could make a lot of people rich.
See More Headlines

BTX Stock Analysis - Frequently Asked Questions

Brooklyn ImmunoTherapeutics' stock was trading at $0.2940 on January 1st, 2025. Since then, BTX stock has increased by 2,308.2% and is now trading at $7.08.

Shares of BTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Brooklyn ImmunoTherapeutics investors own include Mastech Digital (MHH), Altimeter Growth Corp. 2 (AGCB), African Gold Acquisition (AGAC), Aldel Financial (ADF), Adit EdTech Acquisition (ADEX) and Mega Matrix (ACY).

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
N/A
Industry
Television Broadcasting
Sub-Industry
N/A
Current Symbol
NYSE:BTX
CIK
748592
Web
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
$40.69 million
Price / Sales
10.24
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
58,826,000
Free Float
N/A
Market Cap
$416.49 million
Optionable
No Data
Beta
4.61
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (NYSE:BTX) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners